Illumina, Inc.
(NASDAQ : ILMN)

( )
ILMN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
-0.93%291.401.4%$865.23m
AMGNAmgen, Inc.
0.28%221.311.3%$495.03m
CELGCelgene Corp.
0.39%110.001.3%$448.97m
GILDGilead Sciences, Inc.
-0.50%64.321.0%$384.61m
ILMNIllumina, Inc.
0.25%295.733.5%$305.32m
VRTXVertex Pharmaceuticals, Inc.
0.97%203.861.9%$290.09m
REGNRegeneron Pharmaceuticals, Inc.
1.20%348.412.6%$262.04m
EXASEXACT Sciences Corp.
-0.77%79.9124.0%$196.13m
ALXNAlexion Pharmaceuticals, Inc.
0.39%109.442.0%$190.16m
SGENSeattle Genetics, Inc.
2.16%110.646.1%$126.52m
BMRNBioMarin Pharmaceutical, Inc.
0.73%75.884.3%$110.72m
SRPTSarepta Therapeutics, Inc.
5.46%99.9514.6%$106.88m
AAgilent Technologies, Inc.
0.26%77.051.6%$100.02m
MRTXMirati Therapeutics, Inc.
1.12%104.332.3%$89.09m
NBIXNeurocrine Biosciences, Inc.
0.50%111.405.0%$84.24m

Company Profile

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.